Indian drugmakers need more FDA approvals to maintain growth

02/16/2009 | Business Standard (India)

Indian pharmaceutical companies including Dr. Reddy's Laboratories and Sun Pharma would require at least 12 to 14 FDA approvals to achieve their 20% sales growth target in the U.S., according to a Credit Suisse report. Ranbaxy Laboratories, which is under investigation for manufacturing violations, needs 20 more approvals to hit the target this year, the report said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC